SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-09-060916
Filing Date
2009-10-28
Accepted
2009-10-28 17:11:01
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A a09-31868_1s3a.htm S-3/A 481921
2 EX-23.1 a09-31868_1ex23d1.htm EX-23.1 3022
3 EX-23.2 a09-31868_1ex23d2.htm EX-23.2 3798
4 EX-23.3 a09-31868_1ex23d3.htm EX-23.3 2760
5 filename5.htm CORRESP 18669
  Complete submission text file 0001104659-09-060916.txt   511795
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-162613 | Film No.: 091142386
SIC: 2835 In Vitro & In Vivo Diagnostic Substances